Pharmaceutical News

RSS

Asthma medication linked with neuropsychiatric symptoms

In a Pharmacology Research & Perspectives study, the asthma medication montelukast (trade name Singulair) was linked with neuropsychiatric reactions such as depression and aggression, with nightmares being especially frequent in children.

18 Sep 2017

Combination of anti-malarial drug and photosensitizer could effectively kill cancer cells

Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment. Scientists from the National University of Singapore recently showed that its anti-cancer properties could be enhanced by 10 folds when used in combination with Aminolaevulinic acid, a photosensitizer or a drug which, upon exposure to light, leads to generation of free radicals that can kill cells.

18 Sep 2017

Without price breaks, rural hospitals struggle to stock costly, lifesaving drugs

Hospital pharmacist Mandy Langston remembers when Lulabelle Berry arrived at Stone County Medical Center's emergency department last year.

18 Sep 2017

Medical marijuana rarely addressed in medical education

Although 29 states and the District of Columbia allow marijuana use for medical purposes, few medical students are being trained how to prescribe the drug.

15 Sep 2017

‘Deprescribing’ gains support from majority of Canadians over 65, survey shows

Most Canadians over 65 years of age take a lot of prescription drugs -- two-thirds, in fact, take more than five a day, while two out of every five of Canadians over 80 take more than 10 a day. And many worry it's all too much, a new national survey by Université de Montréal researchers has found.

15 Sep 2017

Study examines effectiveness of placebo and antidepressants in children, adolescents

Although the clinical efficacy of antidepressants in children and adolescents is proven, it is frequently accompanied by side effects. In addition, the influence of the placebo effect on the efficacy of antidepressants is unclear.

15 Sep 2017

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies.

14 Sep 2017

Antidepressant users have higher risk of death than non-users, researchers find

Antidepressant medications, most commonly prescribed to reduce depression and anxiety, increase the risk of death, according to new findings by a McMaster-led team of researchers.

14 Sep 2017

FDA grants approval for new biosimilar to treat multiple types of cancer

The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer.

14 Sep 2017

Review assesses safety, effectiveness of corticosteroids for treating TB pericarditis

Researchers from South Africa and Canada have carried out a Cochrane review update to assess the safety and effectiveness of corticosteroids for treating tuberculous pericarditis.

14 Sep 2017

Almirall presents new corporate identity along with strong focus on skin health

Almirall, S.A., presented its new corporate identity today, with which it reinforces its position as a pharmaceutical company specialized in Science and its commitment to providing medical solutions for its customers.

14 Sep 2017

New shingles vaccine gets FDA panel votes

On the 13th of September 2017, a U.S. Food and Drug Administration (FDA) advisory panel has voted 11 to 0 approving a shingles vaccine for its use in adults aged 50 and over. The panel unanimously accepted the safety and efficacy of the vaccine and thus GlaxoSmithKline’s Shingrix is on its way to FDA approval.

14 Sep 2017

Modified blood thinner may be first promising method to prevent repercussions after TBI

A chemically modified version of the common blood thinner heparin may be the first promising method of preventing the harmful cascade of destruction to brain tissue that commonly follows traumatic brain injury (TBI), according to new research findings.

13 Sep 2017

Combination immunotherapy shows better overall survival in kidney cancer patients

A combination immunotherapy treatment showed better overall survival in patients with previously untreated advanced or metastatic renal cell carcinoma than current therapy, according to results from a phase 3 clinical trial presented at the Presidential Symposium of the European Society for Medical Oncology's 2017 Congress in Spain.

13 Sep 2017

FDA moves to guard against abuse of ‘orphan drug’ program

The Food and Drug Administration is changing the way it approves medicines known as "orphan drugs" after revelations that drugmakers may be abusing a law intended to help patients with rare diseases.

13 Sep 2017

MGH researchers identify potential strategy for improving efficacy of angiogenesis inhibitors

A Massachusetts General Hospital research team has identified a potential strategy for improving the efficacy of angiogenesis inhibitors, drugs that help fight cancer by blocking the formation of new blood vessels.

13 Sep 2017

Japanese researchers find new way for increasing effectiveness of drug delivery to brain tumors

For a cancer drug to be successful, it needs to reach the malignant tumor site. Researchers in Japan have now found a way for increasing the effectiveness of drug delivery to certain types of brain tumors, by packing epirubicin, a known antitumor agent, in specially designed polymeric micelles.

13 Sep 2017

Pharmaceutical News

Asthma medication linked with neuropsychiatric symptoms

Combination of anti-malarial drug and photosensitizer could effectively kill cancer cells

Without price breaks, rural hospitals struggle to stock costly, lifesaving drugs

Medical marijuana rarely addressed in medical education

‘Deprescribing’ gains support from majority of Canadians over 65, survey shows

Study examines effectiveness of placebo and antidepressants in children, adolescents

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

Antidepressant users have higher risk of death than non-users, researchers find

FDA grants approval for new biosimilar to treat multiple types of cancer

Review assesses safety, effectiveness of corticosteroids for treating TB pericarditis

Almirall presents new corporate identity along with strong focus on skin health

New shingles vaccine gets FDA panel votes

Modified blood thinner may be first promising method to prevent repercussions after TBI

Combination immunotherapy shows better overall survival in kidney cancer patients

FDA moves to guard against abuse of ‘orphan drug’ program

MGH researchers identify potential strategy for improving efficacy of angiogenesis inhibitors

Japanese researchers find new way for increasing effectiveness of drug delivery to brain tumors

Immunotherapy could help some breast cancer patients based on genetic changes in their tumors

Study finds potential preventive for chemotherapy-induced peripheral neuropathy

Study highlights sharply increasing trend in long-term use of prescription opioids

Could smart vital sign monitoring provide an early warning system for hospitals?

Neurohistology: how whole slide scanning impacts workflow

Analytical Science in Precision Medicine

Latest News